Adagene Inc. (ADAG) Stock Forecast
ADAG analyst forecast
as of October 18, 2026- Analyst consensus
- Strong buy 5.00 / 5 from 6 analysts
- Price target
- $9.91 average of analyst targets
- Upside to target
- +381.0% from the latest close
- Next earnings
- —
- 52-week range
- $1.41 – $4.78
ADAG analyst ratings
6 analystsNumber of analysts at each rating.
ADAG price target
The average of analyst 12-month price targets compared with the latest close and the 52-week range.
ADAG earnings per share estimates
| Period | Average | Low | High | Year ago | Growth | Analysts |
|---|---|---|---|---|---|---|
| Current quarter (Sep '26) | −$0.23 | −$0.23 | −$0.23 | — | — | 1 |
| Current fiscal year (2026) | −$0.51 | −$0.70 | −$0.43 | −$0.30 | −69.3% | 5 |
| Next fiscal year (2027) | −$0.59 | −$1.12 | −$0.18 | −$0.51 | −15.8% | 5 |
Consensus EPS estimates; growth compares the average estimate with the year-ago EPS.
ADAG revenue estimates
| Period | Average | Low | High | Growth | Analysts |
|---|---|---|---|---|---|
| Current quarter (Sep '26) | $0 | $0 | $0 | — | 1 |
| Current fiscal year (2026) | $2.0M | $1.6M | $3.0M | −74.5% | 4 |
| Next fiscal year (2027) | $4.5M | $0 | $18.0M | +129.6% | 4 |
ADAG EPS: reported and forecast
Fiscal years; "E" marks estimates, the line shows the range from the lowest to the highest estimate.
ADAG revenue: reported and forecast
ADAG EPS estimate revisions
| Period | 90 days ago | 60 days ago | 30 days ago | 7 days ago | Now | Change (90 d) | Revisions (30 d) |
|---|---|---|---|---|---|---|---|
| Current quarter (Sep '26) | −$0.07 | −$0.07 | −$0.07 | −$0.07 | −$0.23 | +228.6% | 0 up · 1 down |
| Current fiscal year (2026) | −$0.47 | −$0.41 | −$0.54 | −$0.51 | −$0.51 | +9.0% | 0 up · 0 down |
| Next fiscal year (2027) | −$0.47 | −$0.41 | −$0.59 | −$0.59 | −$0.59 | +25.1% | 1 up · 0 down |
How the consensus EPS estimate changed over the last 90 days, and how many analysts raised or lowered it in the last 30 days.
ADAG earnings surprises
Reported EPS vs the consensus estimate for the last 12 quarters; ADAG beat in 10 of 12.
What analysts expect from ADAG
6 analysts cover Adagene; their consensus rating is strong buy (5.00 on a 1–5 scale, where 5 is a strong buy). The average price target is $9.91, 381.0% above the latest close of $2.06. Analysts expect earnings of −$0.51 per share for 2026, −69.3% from a year earlier. For 2027 the average estimate is −$0.59 per share on revenue of $4.5 million. Adagene beat the EPS estimate in 10 of the last 12 quarters.
Related: ADAG income statement, ADAG key metrics, ADAG chart. See the ADAG stock overview for the latest quote and news.
ADAG forecast FAQ
What is Adagene's price target?
The average analyst price target for Adagene is $9.91, 381.0% above the latest close of $2.06.
Is Adagene a buy, hold or sell?
Of 6 analysts covering Adagene, 6 rate it a strong buy, 0 a buy, 0 a hold, 0 a sell and 0 a strong sell, a consensus of strong buy. Ratings are opinions, not a recommendation from Quotelinks.
What is Adagene's EPS forecast?
Analysts forecast −$0.51 per share for 2026 (range −$0.70 to −$0.43); for 2027 the estimate is −$0.59.
What is Adagene's revenue forecast?
The average revenue estimate for 2026 is $2.0 million, growth of −74.5%; for 2027 it is $4.5 million.
Does Adagene usually beat earnings estimates?
Adagene reported EPS at or above the analyst estimate in 10 of the last 12 quarters.